Annual FCF:
-$176.66M-$153.72M(-670.21%)Summary
- As of today, CDTX annual free cash flow is -$176.66 million, with the most recent change of -$153.72 million (-670.21%) on December 31, 2024.
- During the last 3 years, CDTX annual free cash flow has fallen by -$151.39 million (-599.01%).
- CDTX annual free cash flow is now -16757.06% below its all-time high of -$1.05 million, reached on December 31, 2013.
Performance
CDTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$40.96M-$19.01M(-86.61%)Summary
- As of today, CDTX quarterly free cash flow is -$40.96 million, with the most recent change of -$19.01 million (-86.61%) on June 30, 2025.
- Over the past year, CDTX quarterly free cash flow has increased by +$62.82 million (+60.53%).
- CDTX quarterly free cash flow is now -246.48% below its all-time high of $27.96 million, reached on September 30, 2022.
Performance
CDTX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$129.13M+$62.82M(+32.73%)Summary
- As of today, CDTX TTM free cash flow is -$129.13 million, with the most recent change of +$62.82 million (+32.73%) on June 30, 2025.
- Over the past year, CDTX TTM free cash flow has dropped by -$4.02 million (-3.21%).
- CDTX TTM free cash flow is now -31317.52% below its all-time high of -$411.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CDTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -670.2% | +60.5% | -3.2% |
| 3Y3 Years | -599.0% | -245.6% | -106.8% |
| 5Y5 Years | -518.4% | -189.1% | -120.1% |
CDTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -670.2% | at low | -246.5% | +60.5% | -9652.7% | +32.7% |
| 5Y | 5-Year | -670.2% | at low | -246.5% | +60.5% | -9652.7% | +32.7% |
| All-Time | All-Time | >-9999.0% | at low | -246.5% | +60.5% | >-9999.0% | +32.7% |
CDTX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$40.96M(-86.6%) | -$129.13M(+32.7%) |
| Mar 2025 | - | -$21.95M(+25.4%) | -$191.94M(-8.7%) |
| Dec 2024 | -$176.66M(-670.2%) | -$29.41M(+20.1%) | -$176.66M(-10.3%) |
| Sep 2024 | - | -$36.80M(+64.5%) | -$160.15M(-28.0%) |
| Jun 2024 | - | -$103.78M(-1456.6%) | -$125.11M(-572.2%) |
| Mar 2024 | - | -$6.67M(+48.3%) | -$18.61M(+18.9%) |
| Dec 2023 | -$22.94M(+19.8%) | -$12.90M(-633.0%) | -$22.94M(+26.1%) |
| Sep 2023 | - | -$1.76M(-164.8%) | -$31.05M(-2245.0%) |
| Jun 2023 | - | $2.71M(+124.7%) | -$1.32M(+91.7%) |
| Mar 2023 | - | -$10.99M(+47.7%) | -$15.89M(+44.4%) |
| Dec 2022 | -$28.59M(-13.1%) | -$21.01M(-175.1%) | -$28.59M(-27.1%) |
| Sep 2022 | - | $27.96M(+335.9%) | -$22.49M(+64.0%) |
| Jun 2022 | - | -$11.85M(+50.0%) | -$62.44M(-32.4%) |
| Mar 2022 | - | -$23.69M(-58.9%) | -$47.16M(-86.6%) |
| Dec 2021 | -$25.27M(+53.7%) | -$14.91M(-24.4%) | -$25.27M(-17.6%) |
| Sep 2021 | - | -$11.98M(-450.1%) | -$21.49M(+9.1%) |
| Jun 2021 | - | $3.42M(+289.6%) | -$23.65M(+42.7%) |
| Mar 2021 | - | -$1.80M(+83.8%) | -$41.24M(+24.5%) |
| Dec 2020 | -$54.60M(-91.1%) | -$11.13M(+21.3%) | -$54.60M(+6.9%) |
| Sep 2020 | - | -$14.14M(+0.2%) | -$58.67M(-110.2%) |
| Jun 2020 | - | -$14.17M(+6.6%) | -$27.91M(-5.0%) |
| Mar 2020 | - | -$15.16M(+0.2%) | -$26.58M(+7.0%) |
| Dec 2019 | -$28.57M | -$15.20M(-191.4%) | -$28.57M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $16.62M(+229.5%) | -$27.08M(+52.1%) |
| Jun 2019 | - | -$12.83M(+25.2%) | -$56.56M(+4.6%) |
| Mar 2019 | - | -$17.16M(-25.2%) | -$59.28M(-4.2%) |
| Dec 2018 | -$56.88M(-13.3%) | -$13.71M(-6.5%) | -$56.88M(-7.7%) |
| Sep 2018 | - | -$12.87M(+17.3%) | -$52.81M(+1.8%) |
| Jun 2018 | - | -$15.56M(-5.4%) | -$53.80M(-6.9%) |
| Mar 2018 | - | -$14.75M(-53.2%) | -$50.33M(-0.2%) |
| Dec 2017 | -$50.22M(-25.0%) | -$9.63M(+30.5%) | -$50.22M(+4.2%) |
| Sep 2017 | - | -$13.86M(-14.6%) | -$52.42M(-13.2%) |
| Jun 2017 | - | -$12.09M(+17.4%) | -$46.32M(-5.6%) |
| Mar 2017 | - | -$14.63M(-23.6%) | -$43.87M(-9.2%) |
| Dec 2016 | -$40.17M(-48.1%) | -$11.84M(-52.6%) | -$40.17M(-13.1%) |
| Sep 2016 | - | -$7.76M(+19.5%) | -$35.53M(+0.3%) |
| Jun 2016 | - | -$9.63M(+11.9%) | -$35.63M(-11.4%) |
| Mar 2016 | - | -$10.94M(-51.9%) | -$31.99M(-17.9%) |
| Dec 2015 | -$27.13M(-211.8%) | -$7.20M(+8.3%) | -$27.13M(-16.7%) |
| Sep 2015 | - | -$7.85M(-31.1%) | -$23.25M(-23.8%) |
| Jun 2015 | - | -$5.99M(+1.5%) | -$18.78M(-30.7%) |
| Mar 2015 | - | -$6.08M(-83.3%) | -$14.37M(-65.2%) |
| Dec 2014 | -$8.70M(-730.2%) | -$3.32M(+2.2%) | -$8.70M(-61.6%) |
| Sep 2014 | - | -$3.39M(-114.5%) | -$5.38M(-170.2%) |
| Jun 2014 | - | -$1.58M(-284.7%) | -$1.99M(-384.7%) |
| Mar 2014 | - | -$411.00K | -$411.00K |
| Dec 2013 | -$1.05M | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Cidara Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Cidara Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of CDTX is -$176.66M
What is the all-time high annual free cash flow for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual free cash flow is -$1.05M
What is Cidara Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, CDTX annual free cash flow has changed by -$153.72M (-670.21%)
What is Cidara Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of CDTX is -$40.96M
What is the all-time high quarterly free cash flow for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly free cash flow is $27.96M
What is Cidara Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, CDTX quarterly free cash flow has changed by +$62.82M (+60.53%)
What is Cidara Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of CDTX is -$129.13M
What is the all-time high TTM free cash flow for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM free cash flow is -$411.00K
What is Cidara Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, CDTX TTM free cash flow has changed by -$4.02M (-3.21%)